ArticleProceedings of the National Academy of Sciences of the United States of America2013

Selective Kv1.3 channel blocker as therapeutic for obesity and insulin resistance.

Sanjeev Kumar Upadhyay et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.